Log In
Print
BCIQ
Print
Print this Print this
 

Xolair, omalizumab (RG3648)

Also known as: rhuMAb-E25

  Manage Alerts
Collapse Summary General Information
Company Genentech Inc.
DescriptionRecombinant humanized mAb against IgE
Molecular Target IgE
Mechanism of ActionBinds IgE; Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today